30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Reich Kristian

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Reich Kristian's trades of MoonLake Immunotherapeutics's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-15
PrS Proposed sale
79,692
287.85
US$3,343,993 		79,692 287.85 US$3,343,993
2025-12-10 2025-12-09
S Sale
26,382 +10.8%
335.64
US$1,299,178 		26,382 +10.8% 335.64 US$1,299,178
2025-12-10 2025-12-08
S Sale
75,303 -38.4%
474.83
US$2,126,832 		75,303 -38.4% 474.83 US$2,126,832
2025-12-08 2025-12-08
PrS Proposed sale
202,908
14.80
US$3,003,038 		202,908 14.80 US$3,003,038
2024-02-29 2024-02-28
PlS Planned sale
28,090 -40.1%
55.00
US$1,544,950 		28,090 -40.1% 55.00 US$1,544,950
2024-02-29 2024-02-28
PlS Planned sale
31,910 -1.1%
55.00
US$1,755,050 		31,910 -1.1% 55.00 US$1,755,050
2024-02-29 2024-02-27
PlS Planned sale
29,431 -29.6%
55.00
US$1,618,705 		29,431 -29.6% 55.00 US$1,618,705
2024-02-29 2024-02-27
PlS Planned sale
29,491 -1.0%
55.00
US$1,622,005 		29,491 -1.0% 55.00 US$1,622,005
2024-02-22 2024-02-21
PlS Planned sale
569 -0.6%
55.30
US$31,466 		569 -0.6% 55.30 US$31,466
2024-02-22 2024-02-21
PlS Planned sale
509 -0.0%
55.31
US$28,153 		509 -0.0% 55.31 US$28,153
2024-02-22 2024-02-20
PlS Planned sale
10,000 -9.1%
57.43
US$574,300 		10,000 -9.1% 57.43 US$574,300
2024-02-22 2024-02-20
PlS Planned sale
10,000 -0.3%
57.45
US$574,500 		10,000 -0.3% 57.45 US$574,500
2024-02-16 2024-02-16
PlS Planned sale
10,000 -8.3%
60.15
US$601,500 		10,000 -8.3% 60.15 US$601,500
2024-02-16 2024-02-16
PlS Planned sale
10,000 -0.3%
60.15
US$601,500 		10,000 -0.3% 60.15 US$601,500
2024-02-16 2024-02-15
PlS Planned sale
10,000 -7.7%
60.16
US$601,600 		10,000 -7.7% 60.16 US$601,600
2024-02-16 2024-02-15
PlS Planned sale
10,000 -0.3%
60.17
US$601,700 		10,000 -0.3% 60.17 US$601,700
2024-02-16 2024-02-14
PlS Planned sale
10,000 -7.1%
62.43
US$624,300 		10,000 -7.1% 62.43 US$624,300
2024-02-16 2024-02-14
PlS Planned sale
10,000 -0.3%
62.42
US$624,200 		10,000 -0.3% 62.42 US$624,200
2024-02-14 2024-02-14
PrS Proposed sale
200,000
63.01
US$12,602,000 		200,000 63.01 US$12,602,000